# Synthomer plc (SYNT.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Basic Materials / Chemicals. Price 110p, market value 181 millionp.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Synthomer plc reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.0×**. Each dollar of revenue is priced at 0.0×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.2×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **EV / EBITDA: 3.7×**. Enterprise value is 3.7× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: -48.4%** (5-yr avg 0.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 13.6%**. Synthomer plc keeps 13.6% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -2.0%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -9.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: -17.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -4.9%**. Return on all capital, debt included, is -4.9%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -10.1%**. Each dollar of assets produces -10.1% of profit.

## Growth
- **Revenue growth (1 yr): -12.5%** (3-yr -9.3%/yr, 5-yr 1.1%/yr). Revenue fell 12.5% over the last year, against 1.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -118.2%**. Earnings per share fell 118.2%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -6.7%/yr**. Free cash flow has compounded at -6.7% a year over three years.

## Financial health
- **Debt to equity: 0.91**. Debt is 0.91 times equity, moderate leverage.
- **Net debt / EBITDA: 2.9×**. It would take 2.9 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: -0.5×**. Operating profit covers interest only -0.5×: fragile.
- **Current ratio: 1.57** (quick 0.81). Current assets cover the next year's liabilities 1.57 times.
- **Altman Z-score: 1.52**. A Z-score of 1.52 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Synthomer plc does not currently pay a dividend, but it returned 2.6% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): 86.2%** (YTD 75.4%, 3-mo 6.7%). The shares are up 86.2% over twelve months including dividends.
- **From 52-week high: -11.0%** (560.9% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 67**. An RSI of 67 is neutral.
- **Beta (1 yr): -0.24** (volatility 119%). Beta of -0.24 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SYNT.L · Page: https://foliofundamentals.com/stocks/synt.l

Not investment advice.
